Top 3 Trends In Cell And Gene Therapy

Thanks in part to lessons learned and trends accelerated by COVID-19, there have been many significant developments in cell and gene therapy (CGT) manufacturing. Clinical activity ramped up, and the industry is poised for rapid growth. However, there are long-standing and new challenges to overcome that can hinder this progress.

This article describes three trends will help to address current and future issues, accelerate transformations in CGT and propel the industry forward.